CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Techno Drugs Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Techno Drugs Ltd
J K Tower, 31 Segunbagicha
Phone: +880 258316038p:+880 258316038 Dhaka, 1000  Bangladesh Ticker: TECHNODRUGTECHNODRUG
Business Summary
Techno Drugs Ltd is a pharmaceutical company. The Company is a vertically integrated generic pharmaceutical formulation products manufacturer, marketer, promoter and distributor. The Company manufactures both human pharmaceutical and animal health care drugs. The products of the Company are sold in domestic and international markets. It provides chemotherapeutic agents in Bangladesh for the management of cancer. It is developing positions in therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, lifesaving antibiotics and contrast media in Bangladesh. It offers dosage forms, including tablets, capsules, suspension, and injectable. It manufactures health care medicines like antibiotics, NSAIDS, antiulcerants, gastrointestinal drugs, antidiabetic drugs, cardiovascular drugs, respiratory drugs, and others. Its main products include Levonic Inj (cancer), MTREX, Epicin, Tolfavet-Inj, Td Pyrin, Oxynil, Metafos, Caldimax and Biomix-DB.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20246/30/2023-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board KhaledaAkhter Khan 69 9/30/2009 9/30/2009
Chief Financial Officer Pijush K.Chakroborty 41 2/1/2014 2/1/2014
Chief Sale and Marketing Officer ShoabAhmed 50 1/1/2019 1/1/2019
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,518 (As of 3/31/2024)
Outstanding Shares: 131,998,188 (As of 3/31/2024)
Stock Exchange: DSE
Fax Number: +880 258315821


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024